FDA Inspection 1094014 — Cherokee Pharmaceuticals, LLC
The FDA completed an inspection of Cherokee Pharmaceuticals, LLC on May 8, 2019 in Riverside, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 8, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Riverside, PA (United States)